ANA-NINDS Career Development Symposium Abstract Submission

Submission deadline: May 6, 2025 at 11:59 PM PT. The form will be deactivated on the deadline.

To view more information on ANA2025, please visit our website.

"*" indicates required fields

Presenting Author

Name*

First Last

Credentials*

Please use all uppercase letters (MD, PhD). Please refrain from using periods (M.D., P.h.D.) Be sure to enter your credentials exactly as they should appear in meeting related materials or messaging.

The Presenting Author is a/an*

(i.e. Undergraduate Student, Fellow)

Institution

Institution*

Please provide us with the institution that you are currently at, not where you received your education. Please refrain from using acronyms (UCLA, GSU, FSU). Be sure to enter your institution name exactly as it should appear in any meeting related materials or messaging.

Work Email*

Institution City*

Institution State/Province (if US/Canada)*

Institution Country*

Work Phone*

Contact Information

Primary Email*

Contact Address*

Street Address City ZIP / Postal Code Country

Co-Author Information

Please enter all Co-Authors information below:*

Please include the name, credentials, affiliation, phone number and email address for each co-author with all info on one line for co-author. Click the plus sign on the right to add more co-authors. All authors will be listed in the order you provide them. Please check spelling and grammar.

K-Awardee Information

Please choose one abstract category preference:*

Traditional Categories

Autoimmune Neurology & MS

Behavioral Neurology & Dementia

Cerebrovascular Disease

Epilepsy

Global Neurology

Headache & Pain

Movement Disorders

Neurocritical Care & Traumatic Brain Injury

Neuromuscular Disease

Neuro-oncology

Neuro-ophthalmology & Neurovestibular Disease

Sleep Disorders & Circadian Rhythms

I’d like to choose a Cross Cutting Category

Cross-Cutting Categories

Health Services & Health Equity Research

Neurodegeneration & Cell Death

Neuroinflammation & Neuroinfection

Neurodevelopment

Neurorecover & Neuroplasticity

Neurogenetics & Gene Therapy

Please select which type of K-Award you currently hold:*

Please select year in K-Award (as of October 21, 2024):*

Indicate Area of Primary Research Interest:*

If Other, please explain:

Please identify Research Type:*

Would you like your abstract to be considered for a poster presentation at ANA2025?*

ANA will provide ANA members with two (2) complimentary nights of room & tax at the Baltimore Waterfront Marriott, Baltimore, MD and will cover the costs of full registration for ANA2025 (September 13-16) for K-Awardees to present their research during a poster session. Although it is not required, we hope this support will encourage you to stay and participate in the entire ANA Meeting.

Abstract Body*

Disclosure of Financial Relationships

This disclosure is to be completed by the presenting author/primary contact who may potentially present this abstract as part of the CME for the ANA Annual Meeting. Completion of this form is not intended as acceptance of abstract for this purpose. It is requested as part of this process for decision-making purposes.

Purpose:

ANA is accredited by the ACCME to provide continuing medical education for physicians. As such, we must comply with the ACCME’s policies governing the planning and implementation of continuing medical education, as well as adhere to standards and policies surrounding integrity and independence in CME.

Contact jhurley@myana.org if you have any questions and two short videos that cover the basics of CME planning will be provided upon request.

Disclosure of Financial Relationships:

Organizations accredited by the Accreditation Council for Continuing Medical Education (ACCME) are required to identify and mitigate for any bias resulting from financial relationships with ineligible companies by individuals in a position to influence and/or control the content of CME activities. All individuals in a position to influence and/or control the content of CME activities are required to disclose to us and subsequently to learners: (1) any financial relationships(s) they have or have had with ineligible companies for 24 months prior to the activity, or (2) if they do not have a relevant financial relationship with a ineligible company. Failure to provide disclosure information in a timely manner prior to the individual’s involvement will result in the disqualification of the individual from participating in the CME activity.

Definitions:

Ineligible Company: are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Examples of such organizations include:

• Advertising, marketing, or communication firms whose clients are ineligible companies
• Bio-medical startups that have begun a governmental regulatory approval process
• Compounding pharmacies that manufacture proprietary compounds
• Device manufacturers or distributors
• Diagnostic labs that sell proprietary products
• Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
• Manufacturers of health-related wearable products
• Pharmaceutical companies or distributors
• Pharmacy benefit managers
• Reagent manufacturers or sellers

ACCME focuses on financial relationships with ineligible companies during the 24 months prior to the activity. There is no minimum financial threshold; we ask that you disclose all financial relationships, regardless of the amount, with ineligible companies. You should disclose all financial relationships regardless of the potential relevance of each relationship to the education. Examples of financial relationships include employee, researcher, consultant, advisor, speaker, independent contractor (including contracted research), royalties or patent beneficiary, executive role, and ownership interest, individual stocks and stock options should be disclosed; diversified mutual funds to no need to be disclosed. Research funding from ineligible companies should be disclosed by the principal or name investigator even if that individual’s institution receives the research grant and manages the funds.

Relationships to Disclose:

List the companies and describe the nature of your financial relationship(s) [e.g. Salary, Royalty, Intellectual Property Rights, Consulting Fee, Honoraria for Promotional Speakers’ Bureau, Stocks/Bonds (excluding Mutual Funds), Other (please specify)]. For research funding, only list those where you are the PI.

This author does/does not have any financial relationships (currently or within the last 24 months) with any ineligible companies.*

List the companies and describe the nature of your financial relationship(s). Click the plus sign to the right to add more companies and information.